PERKINELMER INC PKI Cash Flow

Perkinelmer inc (PKI)

CashFlow / Quarterly

Apr'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Apr'18	Dec'17	Sep'17	Jun'17	Mar'17	Jan'17	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Operating activities:
Net income
33,665	64,501	58,558	69,087	35,412	71,292	76,548	64,063	26,024	-41,117	91,078	204,069	38,603	64,849	58,127	63,857	47,466	68,254	54,863	48,974	40,334	30,787	42,277	50,490	34,224	66,873	40,198	27,925	32,216	-15,856	29,594	33,633	22,569	-83,641	36,622	29,761	24,913	295,558	13,391	57,643	24,391
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent
-50	-48	-52	-54	-41	-30	1,103	-610	-11	-2,673	-5,468	141,343	2,541	2,560	4,210	6,101	5,722	23,673	-34	-22	23	30,500	-621	-1,513	-727	-6,582	-565	165	-73	-2,512	605	65	493	-417	8,618	660	-2,378	-	-	-	4,755
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
33,715	64,549	58,610	69,141	35,453	71,322	75,445	64,673	26,035	-38,444	96,546	62,726	36,062	62,289	53,917	57,756	41,744	44,581	54,897	48,996	40,311	287	42,898	52,003	34,951	73,455	40,763	27,760	32,289	-13,344	28,989	33,568	22,076	-83,224	28,004	29,101	27,291	45,548	26,545	47,179	19,636
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:
Restructuring and other costs, net
-5,858	57,296	-14,068	-6,161	-7,639	24,230	-6,508	0	-6,578	25,577	-3,269	0	-9,651	10,248	-656	-4,468	0	-	-	-	-	27,294	-11,092	-5,012	2,135	10,211	1,124	19,247	3,310	4,017	9,672	5,203	6,159	10,112	0	3,340	0	-	-	-	-
Depreciation and amortization
60,758	56,908	53,324	53,324	50,469	47,202	45,161	43,772	44,453	29,493	26,002	24,758	24,747	25,465	24,266	24,846	25,395	21,607	27,164	28,259	28,334	23,632	28,926	28,579	29,328	31,638	33,261	31,409	30,571	30,335	30,628	32,156	32,007	32,203	28,117	26,648	23,953	23,293	22,793	23,076	20,001
Excess tax benefit from exercise of common stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,534	628	0	1,139	18	712	819	7,772	-2,487	58	0	24
Loss (Gain) on disposition of businesses and assets, net
0	-	0	-336	-2,133	-	13,031	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation
3,050	6,409	12,304	6,704	6,097	5,492	11,127	6,816	5,332	9,242	4,412	6,841	4,926	3,709	3,774	5,829	3,846	4,795	4,290	4,206	3,987	2,288	2,450	4,803	4,516	2,630	3,781	3,226	4,416	5,273	5,100	4,776	5,476	6,055	1,467	4,906	3,054	2,064	2,753	4,284	3,315
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
-12,325	-518	1,238	59	3,102	3,835	3,739	6,948	117	602	651	98	811	6,505	4,051	4,305	1,322	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred debt financing costs and accretion of discounts
707	1,068	988	929	861	887	935	904	615	656	705	646	585	630	756	395	356	384	435	365	312	363	409	358	304	3,904	918	867	813	862	910	878	867	3,537	844	635	635	707	636	635	635
Amortization of acquired inventory revaluation
1,088	8,332	7,693	5,282	283	1,112	0	8,952	9,208	1,948	0	2,064	2,176	0	0	265	131	0	808	1,617	4,850	2,425	0	0	0	0	0	74	129	440	0	279	4,495	3,660	54	268	110	-	-	-	0
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:
Accounts receivable, net
-80,600	78,498	12,528	17,468	-7,864	81,842	-6,098	8,488	10,280	47,604	-5,756	19,878	-25,093	24,041	2,283	9,383	-16,747	32,300	-5,518	6,739	-37,582	38,900	-3,407	3,298	-26,732	41,639	-12,079	24,738	-40,227	59,966	-1,615	-7,623	-5,850	37,970	-13,469	20,705	-24,609	37,201	-5,902	9,781	-2,977
Inventories
54,758	-38,760	-2,083	12,009	38,441	-11,130	-1,680	17,965	25,028	-7,285	15,295	3,076	6,837	-20,774	3,414	-6,351	16,959	-22,893	17,497	10,829	22,498	-9,093	12,799	-1,982	17,719	-17,849	14,310	1,523	16,187	-16,587	11,795	-318	12,970	-15,644	14,278	-6,177	9,743	-636	8,555	2,657	11,959
Accounts payable
3,164	41,394	5,908	-38,500	-1,451	45,487	-12,203	-14,358	-10,026	46,790	8,396	-6,972	-13,883	24,853	5,146	-896	1,613	9,019	-18,375	10,794	-12,335	6,856	7,858	-12,826	959	4,431	-9,504	-951	4,941	10,528	-20,256	13,364	-11,719	13,736	4,326	-3,508	-16,330	19,013	-6,805	7,297	8,284
Accrued expenses and other
-61,807	82,096	-37,444	-27,100	-79,325	96,408	-31,510	-18,269	-61,562	98,682	-60,925	-13,064	-42,129	14,708	-13,114	-7,226	-47,908	27,184	3,646	-18,112	-42,895	20,511	-21,154	-17,886	-13,093	48,881	-18,203	-26,564	-89,391	-3,377	-23,131	-20,752	-35,842	35,725	-12,216	8,859	1,473	8,921	-36,310	11,877	8,372
Net cash provided by (used in) operating activities of continuing operations
60,050	215,211	106,715	46,859	-5,316	159,419	93,392	72,985	-14,558	126,992	69,517	54,444	41,202	142,586	73,755	81,148	26,287	101,905	60,768	63,513	37,648	62,245	63,087	54,457	68,113	68,980	48,343	28,807	11,118	40,209	21,104	77,413	15,260	82,546	49,275	54,902	47,280	46,264	6,901	62,801	51,237
Net cash used in operating activities of discontinued operations
0	0	0	0	0	0	-200	0	0	1,104	-11,013	-6,327	12,534	6,137	-141	15,090	5,753	23,334	-43	-42	15	34,319	-160	-62	-402	2,723	-248	-945	-187	-685	-387	-1,023	279	-21	-1,477	-3,002	-4,629	-17,342	8,371	7,866	-1,845
Net cash provided by (used in) operating activities
60,050	215,211	106,715	46,859	-5,316	159,419	93,192	72,985	-14,558	128,096	58,504	48,117	53,736	148,723	73,614	96,238	32,040	125,239	60,725	63,471	37,663	96,564	62,927	54,395	67,711	71,703	48,095	27,862	10,931	39,524	20,717	76,390	15,539	82,525	47,798	51,900	42,651	28,922	15,272	70,667	49,392
Investing activities:
Capital expenditures
20,488	23,249	16,621	16,586	19,875	32,810	20,835	16,956	22,652	16,727	10,889	5,492	5,981	7,291	8,541	8,211	7,659	10,404	7,715	5,620	4,479	4,938	7,767	8,427	6,020	7,427	8,702	11,023	11,829	18,051	12,901	6,221	5,228	5,613	9,009	8,289	7,681	10,764	9,050	6,331	7,501
Increase (Decrease) in Restricted Cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2,000	0	0	0	0	-59	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from surrender of life insurance policies
52	0	0	0	0	0	0	0	72	0	0	45	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments to Acquire Investments
1,638	1,000	4,519	349	519	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of Licenses
0	0	0	0	5,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from Divestiture of Businesses
60	0	0	0	550	0	37,854	173	0	-	-	-	-	0	0	20,000	1,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Activity related to acquisitions, net of cash and cash equivalents acquired
0	147,785	7,882	240,354	4,384	53,629	3,500	39,470	1,087	1,403,605	0	0	123,578	0	61,440	0	10,484	53,305	0	14,116	4,619	269,598	1,529	350	0	8,650	7,000	1,449	-1,400	34,108	6,750	0	0	602,772	918	253,749	56,602	1,386	22,260	123,639	3,089
Net cash used in investing activities of continuing operations
-22,014	-172,034	-29,022	-257,289	-29,228	-87,958	8,019	-56,253	-23,667	-1,453,894	49,531	-5,447	-129,559	-5,291	-69,981	9,833	-17,143	-	-	-	-	-	-	-	-	-16,077	37,063	-12,252	-10,429	-52,342	-19,181	-6,021	-5,228	-	-	-	-	-12,070	-31,310	-120,156	-10,590
Net cash provided by investing activities of discontinued operations
0	0	0	0	0	0	0	0	0	0	-4,203	277,262	-280	-402	-450	-301	-149	-	-	-	-	-	-	-	-	0	-10	371	123	487	988	988	0	-	-	-	-	464,708	-2,407	9,295	-2,321
Net cash used in investing activities
-22,014	-172,034	-29,022	-257,289	-29,228	-87,958	8,019	-56,253	-23,667	-1,453,894	45,328	271,815	-129,839	-5,693	-70,431	9,532	-17,292	-65,123	-6,958	-19,736	-9,039	-272,081	-9,231	-8,565	-6,020	-16,077	37,053	-11,881	-10,306	-51,855	-18,193	-5,033	-5,228	-607,444	-4,768	-233,366	-64,283	452,638	-33,717	-110,861	-12,911
Financing activities:
Payments on borrowings
141,000	273,000	841,489	426,000	152,000	245,000	352,000	520,000	147,000	89,000	1,015	0	145,950	98,000	609,507	120,000	75,000	114,000	122,000	151,000	98,000	51,000	73,000	137,000	95,000	109,000	147,000	147,000	135,000	102,850	89,000	122,000	122,000	267,000	249,000	128,800	118,200	351,000	46,346	49,500	62,000
Proceeds from borrowings
125,000	565,000	184,866	670,550	179,000	252,000	263,000	138,000	204,000	914,000	0	0	146,952	45,000	135,507	57,000	183,000	104,000	163,000	123,000	61,000	248,000	34,000	103,000	90,000	258,000	79,000	127,000	213,000	104,000	81,000	99,000	111,000	207,000	86,000	286,000	208,000	107,000	90,000	139,000	32,000
Payments of debt financing costs
0	1,957	7,741	93	88	0	0	2,634	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	121	1,724	0	0	0	0	0	0	137	279	9,531	1,000	0	0	-	-	-	-
Settlement of cash flow hedges
-8,700	-307	-72	-41	1,700	3,832	-2,411	-3,458	36,169	2,285	7,225	2,745	1,569	3,574	-396	1,352	-2,630	504	4,258	-7,905	-15,563	0	0	0	0	0	0	-523	-840	-4,050	0	0	0	-	-	-	-	-	-	-	-
Net payments on other credit facilities
-4,283	-3,809	-1,360	-6,330	-3,476	-5,512	-12,717	-7,146	-3,008	-1,959	-295	-290	-287	-261	-282	-278	-275	-272	-1,144	607	-263	-11,450	-718	-255	-252	-249	266	-2,758	8,022	5,417	-143	0	0	0	0	-2,265	-38	-38	-37	-37	-37
Payments for acquisition-related contingent consideration
0	-1,742	-4,500	-11,600	-12,100	0	-12,800	0	0	0	0	0	-8,940	-42	-14	-6	-93	-77	-26	0	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-137	0	0	0	-136
Excess tax benefit from exercise of common stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	628	0	1,139	18	712	819	7,772	2,323	58	0	24
Proceeds from issuance of common stock under stock plans
1,106	2,169	1,009	7,944	8,610	5,349	11,136	880	7,468	4,000	781	8,596	4,627	2,337	3,128	7,715	1,238	1,824	412	3,829	8,840	3,508	1,493	12,223	7,231	-35,605	8,003	1,827	5,462	-55,422	11,198	2,247	9,499	-47,406	118	5,522	18,030	-44,206	28,218	-613	-12,434
Purchases of common stock
6,342	112	144	764	5,293	52,471	325	94	4,555	354	215	138	3,127	354	96	192	151,159	281	72,063	141	3,954	26,525	28	35,060	3,916	212	193	135	126,858	12	29	431	1,632	1	7	773	109,224	71,773	0	57	938
Dividends paid
7,781	7,777	7,775	7,764	7,743	7,787	7,751	7,744	7,727	7,716	7,714	7,690	7,673	7,668	7,657	7,631	7,843	7,834	7,938	7,923	7,876	7,907	7,904	7,922	7,887	7,867	7,841	7,832	8,060	8,028	7,984	7,969	7,922	7,916	7,916	7,891	8,106	8,263	8,255	8,247	8,227
Net Cash Provided by (Used in) Financing Activities, Continuing Operations
-24,592	-251,197	170,133	225,959	5,235	-57,268	-109,031	-25,940	13,009	816,686	-15,683	-2,267	-15,967	-62,562	59,797	-64,744	-47,502	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	419,496	-171,093	152,612	-1,903	-307,887	37,544	81,700	-26,880
Cash Provided by (Used in) Financing Activities, Discontinued Operations
0	0	0	0	0	0	0	0	0	0	0	-319	-214	193	0	0	-193	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-1,908	0	0	0	-2,844
Net cash (used in) provided by financing activities
-24,592	-251,197	170,133	225,959	5,235	-57,268	-109,031	-25,940	13,009	816,686	-15,683	-2,586	-16,181	-62,369	59,797	-64,744	-47,695	-14,709	-44,017	-23,723	-24,690	154,626	-47,012	-65,135	-11,548	-15,426	-67,765	-28,375	-42,594	12,111	-7,446	-38,633	-10,195	419,496	-171,093	152,612	-3,811	-307,887	37,544	81,700	-29,724
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
-10,169	3,937	-5,069	235	450	-594	-3,059	-8,201	3,850	1,758	5,017	8,583	6,345	-16,094	600	-3,674	5,746	-2,541	-6,854	3,234	-9,831	-7,971	-8,259	450	728	739	2,450	-1,007	-3,604	836	4,347	-6,078	2,299	-337	-19,043	8,214	21,205	-4,575	16,225	-7,586	-4,720
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent
3,275	-204,083	242,757	15,764	-28,859	13,599	-10,879	-17,409	-21,366	-507,354	93,166	325,929	-85,939	64,567	63,580	37,352	-27,201	42,866	2,896	23,246	-5,897	-28,862	-1,575	-18,855	50,871	40,939	19,833	-13,401	-45,573	616	-575	26,646	2,415	-105,760	-147,106	-20,640	-4,238	169,098	35,324	33,920	2,037
Supplemental Cash Flow Information [Abstract]